SQZ Biotechnologies Announces First Data Presentation on Non-Clinical Studies of Point-of-Care Manuf
SQZ’s Point-of-Care (POC) Manufacturing Platform Shows Promising Results with Ability to Produce Cell Therapies at Scale in Under 10 HoursCo-Development of Research-Use-Only System with STEMCELL Technologies to Help Drive Cell Therapy Innovation by the Broader Scientific CommunityPresentations on the POC Manufacturi...
Source: pharmiweb.com